Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Michael Weinblatt, MD

Harvard Medical School
Waban, MA, United States

John R and Eileen K Riedman Professor of Medicine, Harvard Medical School
R. Bruce and Joan M. Mickey Distinguished Chair in Rheumatology Brigham and Women's Hospital

Presentation(s):

  • 15W109: RA Treatment: Are We Good Enough?

    Wednesday, November 15, 2023
    8:00 AM – 9:00 AM PT

    Disclosure(s): Abbvie: Consultant (Ongoing), Grant/Research Support (Ongoing); Aclaris: Consultant (Ongoing); Amgen: Consultant (Ongoing); Aqtual: Grant/Research Support (Ongoing); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); Canfite: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); CorEvitas: Consultant (Ongoing), Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead: Consultant (Ongoing), Consultant (Ongoing); Glaxo Smith Kline: Consultant (Ongoing); Horizon: Consultant (Ongoing); Inmedix: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Janssen: Grant/Research Support (Ongoing); Johnson and Johnson: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Prometheus Laboratories: Consultant (Ongoing); Rani: Consultant (Ongoing); Revolo: Consultant (Ongoing); Sanofi: Consultant (Ongoing); Sci Rhom: Consultant (Ongoing); Scipher: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Set Point: Consultant (Ongoing); UCB: Consultant (Ongoing)